Annual Total Liabilities
$3.10 M
+$535.00 K+20.83%
December 31, 2023
Summary
- As of February 7, 2025, DMAC annual total liabilities is $3.10 million, with the most recent change of +$535.00 thousand (+20.83%) on December 31, 2023.
- During the last 3 years, DMAC annual total liabilities has risen by +$1.02 million (+49.11%).
- DMAC annual total liabilities is now at all-time high.
Performance
DMAC Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$4.56 M
+$1.18 M+35.07%
September 30, 2024
Summary
- As of February 7, 2025, DMAC quarterly total liabilities is $4.56 million, with the most recent change of +$1.18 million (+35.07%) on September 30, 2024.
- Over the past year, DMAC quarterly total liabilities has increased by +$2.05 million (+81.67%).
- DMAC quarterly total liabilities is now -7.34% below its all-time high of $4.92 million, reached on June 30, 2018.
Performance
DMAC Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
DMAC Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.8% | +81.7% |
| 3 y3 years | +49.1% | +180.1% |
| 5 y5 years | +136.2% | +180.1% |
DMAC Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +103.2% | at high | +216.0% |
| 5 y | 5-year | at high | +116.1% | at high | +337.6% |
| alltime | all time | at high | +5721.8% | -7.3% | +8455.4% |
DiaMedica Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.56 M(+35.1%) |
| Jun 2024 | - | $3.38 M(+16.0%) |
| Mar 2024 | - | $2.91 M(-6.2%) |
| Dec 2023 | $3.10 M(+20.8%) | $3.10 M(+23.6%) |
| Sep 2023 | - | $2.51 M(+8.8%) |
| Jun 2023 | - | $2.31 M(-27.8%) |
| Mar 2023 | - | $3.19 M(+24.4%) |
| Dec 2022 | $2.57 M(+68.2%) | $2.57 M(+30.9%) |
| Sep 2022 | - | $1.96 M(+27.2%) |
| Jun 2022 | - | $1.54 M(+6.9%) |
| Mar 2022 | - | $1.44 M(-5.5%) |
| Dec 2021 | $1.53 M(-26.6%) | $1.53 M(-6.2%) |
| Sep 2021 | - | $1.63 M(+11.8%) |
| Jun 2021 | - | $1.46 M(+20.2%) |
| Mar 2021 | - | $1.21 M(-41.8%) |
| Dec 2020 | $2.08 M(+44.9%) | $2.08 M(+37.6%) |
| Sep 2020 | - | $1.51 M(+15.5%) |
| Jun 2020 | - | $1.31 M(+25.6%) |
| Mar 2020 | - | $1.04 M(-27.4%) |
| Dec 2019 | $1.44 M(+9.3%) | $1.44 M(+7.2%) |
| Sep 2019 | - | $1.34 M(+22.3%) |
| Jun 2019 | - | $1.09 M(-31.0%) |
| Mar 2019 | - | $1.59 M(+20.9%) |
| Dec 2018 | $1.31 M(+31.0%) | $1.31 M(-67.8%) |
| Sep 2018 | - | $4.08 M(-17.1%) |
| Jun 2018 | - | $4.92 M(+55.4%) |
| Mar 2018 | - | $3.17 M(+215.7%) |
| Dec 2017 | $1.00 M(+31.3%) | $1.00 M(-4.9%) |
| Sep 2017 | - | $1.05 M(-13.9%) |
| Jun 2017 | - | $1.23 M(+15.1%) |
| Mar 2017 | - | $1.06 M(+39.3%) |
| Dec 2016 | $764.00 K(-47.5%) | $764.00 K(-48.9%) |
| Sep 2016 | - | $1.50 M(+1.7%) |
| Jun 2016 | - | $1.47 M(+5.2%) |
| Mar 2016 | - | $1.40 M(-4.0%) |
| Dec 2015 | $1.46 M | $1.46 M(+8.3%) |
| Sep 2015 | - | $1.34 M(-8.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $1.47 M(-13.2%) |
| Mar 2015 | - | $1.69 M(-6.6%) |
| Dec 2014 | $1.81 M(+18.8%) | $1.81 M(+28.7%) |
| Sep 2014 | - | $1.41 M(-14.0%) |
| Jun 2014 | - | $1.64 M(-28.2%) |
| Mar 2014 | - | $2.28 M(+49.5%) |
| Dec 2013 | $1.52 M(-3.7%) | $1.52 M(+58.3%) |
| Sep 2013 | - | $962.80 K(+6.4%) |
| Jun 2013 | - | $904.80 K(-46.4%) |
| Mar 2013 | - | $1.69 M(+6.7%) |
| Dec 2012 | $1.58 M(+334.0%) | $1.58 M(+92.9%) |
| Sep 2012 | - | $820.20 K(-12.2%) |
| Jun 2012 | - | $934.50 K(+23.6%) |
| Mar 2012 | - | $756.00 K(+107.4%) |
| Dec 2011 | $364.60 K(-34.2%) | $364.60 K(-23.2%) |
| Sep 2011 | - | $474.70 K(-11.6%) |
| Jun 2011 | - | $536.70 K(-2.9%) |
| Mar 2011 | - | $553.00 K(-0.2%) |
| Dec 2010 | $554.10 K(+180.0%) | $554.10 K(+219.0%) |
| Sep 2010 | - | $173.70 K(-85.6%) |
| Jun 2010 | - | $1.21 M(+118.6%) |
| Mar 2010 | - | $553.00 K(+179.4%) |
| Dec 2009 | $197.90 K(-9.2%) | $197.90 K(+10.8%) |
| Sep 2009 | - | $178.60 K(+202.2%) |
| Jun 2009 | - | $59.10 K(-77.3%) |
| Mar 2009 | - | $260.10 K(+19.3%) |
| Dec 2008 | $218.00 K(-20.0%) | $218.00 K(-12.4%) |
| Sep 2008 | - | $248.80 K(-24.9%) |
| Jun 2008 | - | $331.40 K(+9.5%) |
| Mar 2008 | - | $302.70 K(+11.1%) |
| Dec 2007 | $272.40 K(+411.1%) | $272.40 K(+166.0%) |
| Sep 2007 | - | $102.40 K(-74.0%) |
| Jun 2007 | - | $393.60 K(+155.3%) |
| Mar 2007 | - | $154.20 K(+189.3%) |
| Dec 2006 | $53.30 K(-5.7%) | $53.30 K(-10.0%) |
| Sep 2006 | - | $59.20 K(+4.8%) |
| Dec 2005 | $56.50 K(-95.6%) | $56.50 K |
| Dec 2004 | $1.28 M | - |
FAQ
- What is DiaMedica Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics annual total liabilities year-on-year change?
- What is DiaMedica Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics quarterly total liabilities year-on-year change?
What is DiaMedica Therapeutics annual total liabilities?
The current annual total liabilities of DMAC is $3.10 M
What is the all time high annual total liabilities for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high annual total liabilities is $3.10 M
What is DiaMedica Therapeutics annual total liabilities year-on-year change?
Over the past year, DMAC annual total liabilities has changed by +$535.00 K (+20.83%)
What is DiaMedica Therapeutics quarterly total liabilities?
The current quarterly total liabilities of DMAC is $4.56 M
What is the all time high quarterly total liabilities for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high quarterly total liabilities is $4.92 M
What is DiaMedica Therapeutics quarterly total liabilities year-on-year change?
Over the past year, DMAC quarterly total liabilities has changed by +$2.05 M (+81.67%)